Current Pharmaceutical Design
Title: Editorial [ Therapeutics for Protein Misfolding Diseases Executive Editor: Claudio Soto ]
Volume: 12 Issue: 20
Author(s): Claudio Soto
Affiliation:
Export Options
About this article
Cite this article as:
Soto Claudio, Editorial [ Therapeutics for Protein Misfolding Diseases Executive Editor: Claudio Soto ], Current Pharmaceutical Design 2006; 12 (20) . https://dx.doi.org/10.2174/138161206777698864
DOI https://dx.doi.org/10.2174/138161206777698864 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy
Current Medicinal Chemistry Effects of Therapeutic Hypothermia on the Glial Proteome and Phenotype
Current Protein & Peptide Science Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers Programmed Axon Death, Synaptic Dysfunction and the Ubiquitin Proteasome System
Current Drug Targets - CNS & Neurological Disorders Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules
Current Pharmaceutical Design Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Current Neurovascular Research Trends in Mitochondrial Therapeutics for Neurological Disease
Current Medicinal Chemistry Meet Our Associate Editor:
Current Molecular Medicine Syntheses of Ethyl Pyruvate’s Bioisosteres Inhibiting Inducible Nitric Oxide Production in Lipopolysaccharide-induced BV2 Cells
Letters in Drug Design & Discovery Role of Neurotrophins in Spinal Plasticity and Locomotion
Current Pharmaceutical Design Tracking Stem Cells for Cellular Therapy in Stroke
Current Pharmaceutical Design Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation
Recent Patents on CNS Drug Discovery (Discontinued) Oxidative Stress Protection by Novel Telomerase Activators in Mesenchymal Stem Cells Derived from Healthy and Diseased Individuals
Current Molecular Medicine Effectiveness of the Treatment with Botulinum Toxin Type A (BTX-A) in the Management of the Spasticity in Patients with Amyotrophic Lateral Sclerosis (ALS)
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Neurotrophic and Antiangiogenic Functions of PEDF: A Reflection of its Variable Phosphorylation States
Current Genomics Development of Neurotrophic Molecules for Treatment of Neurode-generation
Current Protein & Peptide Science Cell Microencapsulation Implants into the Central Nervous System
Recent Patents on Nanomedicine Metabotropic Glutamate Receptors in the Control of Neuronal Activity and as Targets for Development of Anti-Epileptogenic Drugs
Current Medicinal Chemistry Sirtuins: Common Targets in Aging and in Neurodegeneration
Current Drug Targets Patent Selections
Recent Patents on Biomarkers